Sivers Semiconductors Faces Reckoning as Nasdaq Ambitions Trigger Accounting Overhaul and 40% Monthly Tumble

Swedish chip developer Sivers' stock sheds 40% in a month as dilution, auditor doubts, and short selling weigh; revised reporting calendar for Nasdaq listing adds uncertainty.

The connection between corporate ambition and shareholder pain has rarely been this direct. Sivers Semiconductors, the Swedish chip developer targeting a dual listing on the Nasdaq, has watched its stock shed roughly 40 percent in the past month, while simultaneously pushing back its financial reporting calendar to meet US compliance standards. At €4.18, the shares now trade 59 percent below the June 3 high of €10.23 and some 33 percent beneath the 50-day moving average of €6.22 — though they remain above the 100-day average of €3.72.

The catalyst for the slide is no mystery. Sivers completed an accelerated share placement in recent weeks, and a debt holder converted a dollar-denominated loan into equity, flooding the market with nearly 23 million new shares. That dilution has spooked investors, as has a warning from the company’s auditor over going-concern doubts and an active campaign by short sellers levelling serious allegations against the business. The 30-day annualised volatility has surged to an extraordinary 223 percent, while the relative strength index at 38.6 suggests the stock is bruised but not yet oversold.

Amid this turbulence, the company announced on 9 July that it is revising its reporting schedule to align with US Generally Accepted Accounting Principles and the audit standards of the Public Company Accounting Oversight Board. The interim report for the second quarter of 2026 is now due on 27 August 2026, followed by the third-quarter report on 26 November 2026 and the fourth-quarter report on 25 February 2027. Management frames the delay as part of strengthening internal controls and ensuring “the highest standards of accuracy, transparency and compliance” as it prepares for a Nasdaq listing targeted around the turn of the year.

The timing adds a layer of tension. A lock-up agreement preventing CEO Vickram Vathulya, CFO Heine Thorsgaard and the rest of the board from selling shares expires on 16 July 2026 — roughly six weeks before the first set of numbers under the new framework. Investors will be watching closely to see whether insiders choose to exit once the restriction lifts, a move that could deepen the downward pressure on a stock that has already lost nearly half its value in a month. The revised reporting calendar, meanwhile, means the market must wait longer for a verdict on whether the capital-raising and debt restructuring are translating into genuine operational progress. If they are not, the Nasdaq dream may recede further into the distance.